Completed
Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer
NCT01238952
- Conditions
- Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Sarah Cannon Research Institute Nashville, Tennessee, United States